Similarly, the higher expression of Smad4 in the papillary adenocarcinoma tumors as potential compensation for the better expression of members the TGF-β-Smad3 pathway in the carcinomas has to be elucidated. Here, SMAD4 is linked to papillary adenocarcinoma.